IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RANDON, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.941
AS - Asia 2.382
NA - Nord America 2.167
SA - Sud America 254
AF - Africa 56
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.822
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.060
DE - Germania 1.390
CN - Cina 779
SG - Singapore 622
IT - Italia 503
BD - Bangladesh 243
GB - Regno Unito 212
BR - Brasile 193
SE - Svezia 191
VN - Vietnam 151
HK - Hong Kong 147
IN - India 135
FR - Francia 131
RU - Federazione Russa 124
JP - Giappone 106
CA - Canada 82
NL - Olanda 68
FI - Finlandia 54
ES - Italia 53
TR - Turchia 51
IE - Irlanda 49
DK - Danimarca 35
CI - Costa d'Avorio 28
ID - Indonesia 28
PL - Polonia 27
AR - Argentina 22
BE - Belgio 17
UA - Ucraina 17
AU - Australia 15
CH - Svizzera 15
KR - Corea 14
MX - Messico 13
TW - Taiwan 13
IQ - Iraq 12
PK - Pakistan 11
UZ - Uzbekistan 11
AT - Austria 10
CL - Cile 9
EC - Ecuador 9
ZA - Sudafrica 9
PH - Filippine 8
SA - Arabia Saudita 8
CO - Colombia 6
GR - Grecia 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
IR - Iran 5
MY - Malesia 5
PT - Portogallo 5
RS - Serbia 5
AL - Albania 4
CZ - Repubblica Ceca 4
EG - Egitto 4
HU - Ungheria 4
JO - Giordania 4
RO - Romania 4
TH - Thailandia 4
VE - Venezuela 4
AP - ???statistics.table.value.countryCode.AP??? 3
BO - Bolivia 3
DZ - Algeria 3
MO - Macao, regione amministrativa speciale della Cina 3
NZ - Nuova Zelanda 3
PE - Perù 3
SI - Slovenia 3
UY - Uruguay 3
BB - Barbados 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
PY - Paraguay 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GL - Groenlandia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KW - Kuwait 1
LC - Santa Lucia 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
QA - Qatar 1
SD - Sudan 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 7.818
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.291
Singapore 379
Ashburn 339
Chandler 222
Southend 146
San Jose 133
Hong Kong 118
Milan 117
Beijing 108
Los Angeles 88
New York 69
Dallas 67
Santa Clara 64
Fairfield 58
Council Bluffs 57
Shanghai 56
Dublin 49
Wilmington 49
Redwood City 48
Ho Chi Minh City 47
Princeton 47
Helsinki 43
Bengaluru 39
Ann Arbor 38
Dearborn 38
Hanoi 37
Houston 35
Toronto 35
Guangzhou 33
Cambridge 32
Rome 31
Tokyo 31
Munich 30
Woodbridge 30
Lauterbourg 29
Abidjan 28
Boardman 27
Istanbul 27
Buffalo 25
Seattle 25
Nanjing 24
Shenyang 23
Changsha 22
Des Moines 22
Jakarta 22
Moscow 22
Chicago 20
São Paulo 20
Tianjin 20
Hangzhou 19
Naples 19
Phoenix 19
Columbus 16
Fuzhou 16
Pune 16
Brussels 14
Grafing 14
Paris 14
Wuhan 14
Amsterdam 13
Jinan 13
Montreal 13
Mumbai 13
The Dalles 13
Central District 12
London 12
Cangzhou 11
Genoa 11
Hefei 11
Hyderabad 11
Turin 11
Turku 11
Bari 9
Bologna 9
Nanchang 9
San Francisco 9
Seoul 9
Warsaw 9
Chengdu 8
Rio de Janeiro 8
San Diego 8
Fremont 7
Johannesburg 7
New Delhi 7
Ningbo 7
Nuremberg 7
Palermo 7
Shenzhen 7
Stockholm 7
Taipei 7
Zhengzhou 7
Bergamo 6
Da Nang 6
Falls Church 6
Haiphong 6
Lille 6
Taizhou 6
Atlanta 5
Barcelona 5
Belo Horizonte 5
Totale 4.875
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer 871
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 527
The added value of baseline circulating tumor DNA profiling in patients with molecularly hyperselected, left-sided metastatic colorectal cancer 418
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer 371
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 324
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan 304
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei 288
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel : A Translational Analysis from the ITACA-S Trial. Oncologist 287
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 281
The landscape of actionable gene fusions in colorectal cancer 277
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer 260
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer 250
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 242
Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-l1 monoclonal antibodies 241
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers 239
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial 237
Atypical RAS Mutations in Metastatic Colorectal Cancer 228
Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake 223
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer 221
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation 207
KRAS G12C Metastatic Colorectal Cancer : Specific Features of a New Emerging Target Population 199
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study 191
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy 183
MGMT Promoter Methylation as a Target In Metastatic Colorectal Cancer : Rapid Turnover and Use of Folates Alter its Study-Response 174
“Systemic strategy at the patient’s service”: A congress report on supportive care in oncology 167
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study 156
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma 147
The Italian instrument evaluating the nursing students clinical learning quality 130
Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience 125
Management of patients with locally recurrent rectal cancer with a previous history of distant metastases: retrospective cohort study 125
Nursing students’ experience of the mental health setting as a clinical learning environment: Findings from a national study 117
Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO 23
null 3
Totale 8.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.614
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 0 0 67
2021/2022671 60 56 46 41 32 41 34 46 72 83 24 136
2022/2023714 72 102 81 71 57 120 21 60 52 13 46 19
2023/20241.323 26 36 46 49 86 42 221 167 84 158 202 206
2024/20251.691 184 213 156 197 101 90 102 115 58 118 143 214
2025/20262.596 254 144 233 147 229 128 334 73 196 167 397 294
Totale 8.036